Oglionucleotide Cards

SOL #: N0017326Q5252Special NoticeSole Source

Overview

Buyer

Dept Of Defense
Dept Of The Navy
NAVAL RESEARCH LABORATORY
WASHINGTON, DC, 20375-5328, United States

Place of Performance

Washington, DC

NAICS

In-Vitro Diagnostic Substance Manufacturing (325413)

PSC

In Vitro Diagnostic Substances, Reagents, Test Kits And Sets (6550)

Set Aside

No set aside specified

Timeline

1
Posted
Jun 22, 2026
2
Action Date
Jun 24, 2026, 2:00 PM

Qualification Details

Fit reasons
  • NAICS alignment with historical contract wins in similar service areas.
  • Scope strongly matches core technical capabilities and delivery model.
Risks
  • Past performance thresholds may require one additional teaming partner.
  • Potential clarification needed on staffing minimums before bid/no-bid.
Next steps

Validate eligibility requirements, assign capture owner, and schedule partner outreach to confirm teaming strategy before submission planning.

Quick Summary

The Naval Research Laboratory (NRL), part of the Department of the Navy, has issued a Notice of Intent to Award a Sole Source purchase order to INTEGRATED DNA TECHNOLOGIES for OGLIONUCLEOTIDE CARDS. This is not a request for competitive proposals. Interested parties must submit evidence of their capability to meet this requirement by June 24, 2026.

Purpose

This notice serves as a declaration of the Naval Research Laboratory's intent to award a sole source purchase order for OGLIONUCLEOTIDE CARDS. The government has determined that only one responsible source, INTEGRATED DNA TECHNOLOGIES, can satisfy agency requirements. This is explicitly stated as not a solicitation or a request for offers.

Requirement Details

The requirement is for OGLIONUCLEOTIDE CARDS. The procurement falls under NAICS Code 325413 (Pharmaceutical Preparation Manufacturing) with a size standard of 1250 employees, and Product Service Code (PSC) 6550 (In Vitro Diagnostic Substances, Reagents, Test Kits And Sets).

Contract & Timeline

The purchase will be made utilizing Simplified Acquisition Procedures in accordance with Federal Acquisition Regulation (FAR) 12.201-1, for purchases not exceeding the simplified acquisition threshold of $350,000.

  • Opportunity Type: Special Notice (Notice of Intent to Award Sole Source)
  • Intended Awardee: INTEGRATED DNA TECHNOLOGIES
  • Response Deadline for Interest: June 24, 2026, at 2:00 PM ET
  • Published Date: June 22, 2026

Action for Interested Parties

Interested parties capable of fulfilling this requirement must identify their interest and provide clear and convincing evidence that competition would be advantageous to the Government. Responses must be submitted within fifteen (15) calendar days of the notice's publication. Information received will be considered solely for determining whether to conduct a competitive procurement. A determination by the Government not to compete this proposed purchase order based upon response to this notice is solely within the discretion of the Government. No reimbursement for providing capability information will be provided.

Contact Information

For inquiries, please contact Richard Key at richard.a.key2.civ@us.navy.mil. Please reference the Notice of Intent number in all correspondence.

People

Points of Contact

Files

Files

No files attached to this opportunity

Versions

Version 1Viewing
Special Notice
Posted: Jun 22, 2026
Oglionucleotide Cards | GovScope